Post-Exposure Rabies Prophylaxis Duration
For previously unvaccinated patients, administer 4 doses of rabies vaccine on days 0,3,7, and 14, along with rabies immunoglobulin (RIG) on day 0; for previously vaccinated patients, give only 2 doses of vaccine on days 0 and 3, with NO immunoglobulin. 1
Previously Unvaccinated Patients (Vaccine-Naïve)
The ACIP guidelines establish a clear 4-dose vaccine schedule spanning 14 days 1:
- Day 0: First vaccine dose (1.0 mL IM) + RIG (20 IU/kg body weight)
- Day 3: Second vaccine dose
- Day 7: Third vaccine dose
- Day 14: Fourth vaccine dose
Critical Implementation Details:
Vaccine administration:
- Use HDCV (human diploid cell vaccine) or PCECV (purified chick embryo cell vaccine)
- Inject in the deltoid muscle for adults and older children
- Use anterolateral thigh for younger children
- Never use the gluteal area - this produces diminished immune response 1
RIG administration:
- Give only once on day 0
- Infiltrate as much as anatomically feasible around and into the wound(s)
- Inject remaining volume IM at a site distant from vaccine administration
- If RIG wasn't given on day 0, it can still be administered up to and including day 7 1
- Do not exceed the recommended dose as it may suppress active antibody production
Important Exception - Immunocompromised Patients:
Use a 5-dose schedule (days 0,3,7,14, and 28) for any immunosuppressed patient 1. This is a critical caveat that must not be missed.
Previously Vaccinated Patients
Only 2 vaccine doses are required - a dramatically simplified regimen 1:
- Day 0: First dose (1.0 mL IM)
- Day 3: Second dose
Key Points:
- No RIG should be given to previously vaccinated patients - it may inhibit the anamnestic response 1
- "Previously vaccinated" means any person with:
- Prior pre-exposure vaccination with HDCV, PCECV, or RVA
- Prior PEP with these vaccines
- Any other rabies vaccine with documented antibody response 1
Wound Care (All Patients)
Regardless of vaccination status, immediately cleanse all wounds thoroughly with soap and water. If available, use a virucidal agent like povidone-iodine solution 1. This is a critical first step that should never be delayed.
Evidence Strength
This recommendation comes from the 2010 ACIP guidelines published in MMWR 1, which reduced the schedule from 5 to 4 doses based on extensive evidence review 2. The 4-dose regimen has been validated as safe and effective, inducing adequate long-lasting antibody responses when combined with timely wound care and RIG 3. The American Academy of Pediatrics endorses these recommendations 4.
Common Pitfall: Do not confuse the immunocompetent 4-dose schedule with the immunosuppressed 5-dose schedule. Always assess immune status before determining the regimen. Missing this distinction could result in inadequate protection for vulnerable patients.